Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2023 | Effect of anti-obesity agent HSG4112 on overweight and obese patients following 12 weeks of oral treatment: a study protocol for a randomised, double-blind, placebo-controlled, parallel-group, phase 2a clinical trial | FRONTIERS IN PHARMACOLOGY |